Skip to main content
logo
ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
13.62
+0.12 (0.89%)
At close: Aug 10, 2026, 4:00 PM EDT
13.45
-0.17 (-1.25%)
After-hours: Aug 10, 2026, 5:53 PM EDT

ORIC Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,412806573505266580
Market Cap Growth
47.13%40.62%13.55%90.06%-54.18%-53.31%
Enterprise Value
1,153524.48317.19296.5859.31342.64
Last Close Price
13.628.188.079.205.8914.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.672.102.362.251.192.12
P/TBV Ratio
3.711.872.312.111.052.04

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.69-0.73-1.05-0.93-0.93-0.87
Net Debt / EBITDA Ratio
1.711.991.811.902.273.04
Net Debt / FCF Ratio
2.362.522.252.412.673.92
Quick Ratio
12.7613.7910.3010.1813.4015.64
Current Ratio
13.1914.1310.5610.3913.6815.88
Return on Equity (ROE)
-36.66%-41.27%-54.73%-45.11%-35.99%-28.03%
Return on Assets (ROA)
-38.38%-41.87%-54.32%-44.38%-33.63%-26.39%
Return on Invested Capital (ROIC)
-124.21%-216.16%-557.07%-291.02%-193.52%-261.08%
Return on Capital Employed (ROCE)
-40.43%-44.85%-59.44%-47.82%-35.62%-27.51%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-43.06%-25.91%-35.52%-29.75%-4.48%-72.97%
Total Shareholder Return
-43.06%-25.91%-35.52%-29.75%-4.48%-72.97%
SEC Filings: 10-K · 10-Q